MGC Pharmaceuticals Ltd (ASX:MXC) announced that it passed 2,000 prescribed units’ level of its standardised, affordable cannabinoid medicines.
The increase in the prescribed units was from the patients in Australia, the UK along with the recent additions of new patient special access approved markets of Brazil & Ireland after the recent approval for selling MGC Pharma products in these nations.
The company also confirmed the successful arrival of its first shipment in Brazil after an initial purchase order from ONIX Empreendimentos e Participações (‘Onix’) in November 2019.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.